Neurological implications of antenatal corticosteroids on late preterm and term infants: a scoping review

Emily B Sarid1, Michelle L Stoopler1, Anne-Maude Morency2

  • 1Department of Pediatrics, McGill University, Montreal, QC, Canada.

Pediatric Research
|June 10, 2022
PubMed

Insights

Antenatal corticosteroids (ACS) given for preterm birth risk may impact brain development in late preterm and term infants. Studies show potential adverse outcomes like reduced head circumference and neurodevelopmental delays.

Area of Science:

  • Perinatology
  • Neurodevelopmental Pediatrics
  • Obstetrics

Background:

  • Antenatal corticosteroids (ACS) are administered to mothers at risk of preterm birth.
  • A significant proportion of fetuses exposed to ACS are born late preterm or at term.
  • The neurological effects of ACS on these infants are not fully understood.

Purpose of the Study:

  • To synthesize existing knowledge on the association between ACS exposure and brain development in infants born late preterm and term.
  • To identify neurological outcomes associated with ACS exposure in this population.
  • To highlight gaps and biases in current research.

Main Methods:

  • Systematic search of three databases and eight conference proceedings (1972-2021).
  • Inclusion criteria: ACS for preterm delivery risk, late preterm/term infant cohort, brain development assessment.
  • Qualitative synthesis of data from 27 included studies.

Main Results:

  • ACS exposure was linked to adverse brain development outcomes in late preterm and term infants.
  • Commonly reported outcomes include reduced neonatal head circumference and cortical differences on MRI.
  • Increased prevalence of psychiatric problems and neurodevelopmental delays were also observed.

Conclusions:

  • ACS exposure for preterm birth risk may have significant neurological implications for infants born at or near term.
  • Existing research is limited by serious risk of bias.
  • Further research is needed to control for confounders like preterm labor, maternal stress, and ACS dosage.